Paradigm Biopharmaceuticals Limited Stock Forecast

Paradigm Biopharmaceuticals Limited stock price down 0% on Friday
(Updated on Apr 19, 2024)

PAR.AX Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 15, 2024, and so far it has risen 3.64%. Further rise is indicated until a new top pivot has been found. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". Some negative signals were issued as well, and these may have some influence on the near short-term development. The Paradigm Biopharmaceuticals Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.286 and $0.346. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Paradigm Biopharmaceuticals Limited stock

Paradigm Biopharmaceuticals Limited finds support from accumulated volume at $0.280 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0200 between high and low, or 7.14%. For the last week, the stock has had daily average volatility of 9.33%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PAR.AX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Paradigm Biopharmaceuticals Limited to open at $0.288, and during the day (based on 14 day Average True Range), to move between $0.260 and $0.310, which gives a possible trading interval of +/-$0.0247 (+/-8.67%) up or down from last closing price. If Paradigm Biopharmaceuticals Limited takes out the full calculated possible swing range there will be an estimated 17.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.280 (1.75%) than the resistance at $0.315 (10.53%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Paradigm Biopharmaceuticals Limited stock A Buy?

Paradigm Biopharmaceuticals Limited holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.726 Sell Candidate Unchanged

Predicted Opening Price for Paradigm Biopharmaceuticals Limited of Monday, April 22, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.